Allylglycine: intranigral effects and reappraisal of actions on the GABA system.
D000612:4-Aminobutyrate Transaminase / Q000378:metabolism; D000596:Amino Acids / Q000096:biosynthesis; D000818:Animals; D001921:Brain / Q000201:enzymology; D003292:Convulsants / Q000494:pharmacology*; D005968:Glutamate Decarboxylase / Q000378:metabolism; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009498:Neurotoxins; D011731:Pyridoxal Kinase / Q000378:metabolism; D011732:Pyridoxal Phosphate / Q000378:metabolism; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism / Q000502:physiology*
D000596:Amino Acids; D003292:Convulsants; D009498:Neurotoxins; D005680:gamma-Aminobutyric Acid; D011732:Pyridoxal Phosphate; D000612:4-Aminobutyrate Transaminase; D011731:Pyridoxal Kinase; D005968:Glutamate Decarboxylase; D005998:Glycine